Find similiar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL08553/0466.
Molita 200mg/25mg Modified Release Capsules, Hard
Molita 200 mg/25 mg Modified-Release Capsules, Hard
Dipyridamole and aspirin
1. What Molita is and what it is used for
2. What you need to know before you take Molita
3. How to take Molita
4. Possible side effects
5. How to store Molita
6. Contents of the pack and other information
The name of your medicine is Molita. It contains two different medicines called dipyridamole and aspirin. Both belong to a group of medicines called ‘anti-thrombotic medicines’. Aspirin is also a type of medicine called a ‘Non-Steroidal Anti-inflammatory Drug’ (NSAID).
Molita belongs to a group of medicines called ‘anti-thrombotic agents’. They are used to stop blood clots forming. Molita is used for people who have had a
which are caused by a clot in the brain. This medicine reduces the risk of them happening again.
Do not take Molita if you:
Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Molita.
Talk to your doctor or pharmacist before taking Molita if you:
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Molita.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
Molita contains dipyridamole. Dipyridamole is also sometimes given as an injection during tests to see if the heart is working properly (also called ‘myocardial imaging’). This means that the test and your medicine may contain the same substance. If you are going to have an injection of dipyridamole, tell the doctor that you are taking Molita.
Do not take Molita if you are in the last three months of pregnancy. If you are in the first six months of pregnancy, likely to get pregnant or are breast-feeding, talk to your doctor before taking this medicine.
You may feel dizzy or confused while taking Molita. If this happens do not drive or use any tools or machines.
If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact your doctor before taking this medicine.
Molita also contains methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216) and colourings ponceau 4R (E124) and sunset yellow (E110), which may cause allergic reactions.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
If you get a severe migraine-like headache at the start of your treatment tell your doctor as they may need to change your dose for a short period of time. DO NOT take painkillers containing aspirin to treat your headache.
This medicine should not be given to children.
If you take more of this medicine than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you, even if there are no capsules left.
If you forget a dose, take it as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for the forgotten dose.
Do not stop treatment without talking to your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.
Bleeding at different sites within the body can occur which in some cases may be serious. The following have been seen with Molita.
Common (affects less than 1 in 10 people but more than 1 in 100 people)
Uncommon (affects less than 1 in 100 people but more than 1 in 1,000 people)
Unknown (incidence cannot be estimated)
Allergic reactions are common. If you have an allergic reaction stop taking your medicine and see a doctor straight away. The signs may include difficulty breathing, rash which may be severe with itching, or swelling of the throat or face.
Very Common (affects more than 1 in 10 people)
Common (affects less than 1 in 10 people but more than 1 in 100 people)
Uncommon (affects less than 1 in 100 people but more than 1 in 1,000 people)
Rare (affects less than 1 in 1,000 people but more than 1 in 10,000 people)
In addition, there are other side effects that are known for the active ingredients dipyridamole and aspirin when taken on their own. These are listed below and also apply to Molita.
In people who have gallstones, dipyridamole can be absorbed into the gallstones.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special temperature storage conditions.
Store in the original package in order to protect from moisture. Keep the bottle tightly closed.
Do not use this medicine after the expiry date which is stated on the carton and the bottle label. The expiry date refers to the last day of that month.
Do not open the bottle until you are ready to start taking the capsules. If you have any capsules left in the bottle after 30 days, these should not be taken.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substances are dipyridamole and aspirin. Each capsule contains dipyridamole 200 mg in modified release form and 25 mg aspirin in standard release form.
The other ingredients are: Dipyridamole pellets – tartaric acid, hypromellose, acacia, talc, povidone, methacrylic acid-methyl methacrylate copolymer, hypromellose phthalate, dimethicone, triacetin, stearic acid; Aspirin tablet – microcrystalline cellulose, anhydrous lactose, corn starch, colloidal anhydrous silica, stearic acid, polyvinyl alcohol, titanium dioxide, talc, quinoline yellow (E104), soya lecithin (E322), xanthan gum (E415); Capsule shells – gelatine, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), ponceau 4R (E124), patent blue (E131), quinoline yellow (E104), sunset yellow (E110), titanium dioxide (E171).
Capsule (size 0xEL) with orange coloured cap and white to off-white coloured body.
Molita is available in plastic bottles with child-proof closure containing 30, 50, 60 (1 x 60), 60 (2x30) or 100 (2 x 50) capsules.
Not all pack sizes may be marketed.
This leaflet was last revised in 02/2017